Filter
1633
Text search:
hiv
drug
resistance
Featured
216
481
Language
Document type
951
260
219
73
48
34
29
11
3
2
1
1
Countries
87
71
54
44
42
41
40
39
39
36
25
25
25
24
24
23
20
20
20
18
18
15
14
14
13
12
11
11
11
10
10
8
8
7
7
6
6
6
5
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
671
183
63
57
45
24
20
1
Toolboxes
414
141
131
48
44
41
35
34
32
23
20
19
17
14
14
11
11
9
9
6
4
3
2
1
1
ATIC Newsletter, Vol 15, Issue 1,
February 2022.
This study aimed to understand the patterns of HIV drug resistance in pregnant women in Mozambique. This might help in tailoring optimal regimens f
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention
...
HIV drug resistance strategies focus on prevention through adherence and treatment optimization, surveillance to monitor
...
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for
...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specim
...
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug
...
CDC leads an international surveillance effort to estimate the occurrence of HIV drug resistance among people with
...
Developed through broad and inclusive consultation, and aligned with the WHO Global Health Sector Strategies and the Sustainable Development Goals, the framework promotes a people-centred approach and antimicrobial stewardship across 5 key domains: prevention and response, surveillance, research and
...
During ARV drug pressure the HIV-1 RT is able to develop resistance to these drugs by generating mutations
Topics in Antiviral Medicine, March 4, 2025
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acq
...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex F
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results fr
...
Open Forum Infect Dis . 2022 Apr 5;9(5):ofac148.doi: 10.1093/ofid/ofac148. eCollection 2022 May. Dolutegravir HIV drug resistance (HIVDR) data from
...
